Quadrature Capital’s Zura Bio ZURA Stock Holding History

Quadrature Capital’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,572	Closed	-$192K	–	1936
2025 Q4	$192K	Buy	+36,572	New	+$145K	﹤0.01%	984
2025 Q3	–	Sell	-15,158	Closed	-$15.8K	–	1563
2025 Q2	$15.8K	Buy	+15,158	New	+$18.1K	﹤0.01%	995

Other funds holding ZURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Quadrature Capital's ZURA Position: Q1 2026 in Review

Quadrature Capital sold out of Zura Bio (ZURA) in Q1 2026, closing a stake of 36,572 shares — an estimated $192K sold.

Quadrature Capital first reported a position in ZURA in Q2 2025 and held it in 2 quarters. The position peaked at $192K in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

Quadrature Capital reported no remaining Zura Bio position as of Q1 2026 after selling out during the quarter.
Quadrature Capital sold 36,572 Zura Bio shares in Q1 2026, an estimated $192K.
Quadrature Capital first reported a position in Zura Bio in Q2 2025 and held it in 2 quarters.
Quadrature Capital's Zura Bio position peaked at $192K in Q4 2025.
94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.